Galectin-3: an early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months

BACKGROUND: Bronchial asthma is a heterogeneous disease characterized by three cardinal features: chronic inflammation, variable airflow obstruction, and airway hyperresponsiveness. Asthma has traditionally been defined using nonspecific clinical and physiologic variables that encompass multiple phe...

Descripción completa

Detalles Bibliográficos
Autores principales: Riccio, Anna Maria, Mauri, Pierluigi, De Ferrari, Laura, Rossi, Rossana, Di Silvestre, Dario, Benazzi, Louise, Chiappori, Alessandra, Dal Negro, Roberto Walter, Micheletto, Claudio, Canonica, Giorgio Walter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345272/
https://www.ncbi.nlm.nih.gov/pubmed/28293414
http://dx.doi.org/10.1186/s13601-017-0143-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345272/
https://www.ncbi.nlm.nih.gov/pubmed/28293414
http://dx.doi.org/10.1186/s13601-017-0143-1

Ejemplares similares